Lexaria Bioscience LEXX
NASDAQ LEXX
$10.91 -0.36 (-3.15%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Other Operating Expenses (2017 - 2022)

Lexaria Bioscience (LEXX) posted Other Operating Expenses of $1.5 million for Q3 2022, little changed sequentially from $1.5 million in Q1 2021.

Lexaria Bioscience (LEXX) Other Operating Expenses (2017 - 2022) Analysis & Trends

Lexaria Bioscience has reported Other Operating Expenses for 6 years, with the latest figure at $1.5 million in Q3 2022.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $1.5 million in Q3 2022, while the trailing twelve-month figure through May 2023 was $1.5 million (changed N/A YoY) and the FY2022 annual result came in at $1.5 million, changed 0.0% from the prior year.
  • Other Operating Expenses held at $1.5 million in Q3 2022 per LEXX's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $1.5 million in Q1 2021 and troughed at -$852261.0 in Q4 2020.
  • A 5-year average of $614977.5 and a median of $882705.0 in 2019 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2019 and 2020: Other Operating Expenses soared 27244.15% in 2019, then slumped 196.55% in 2020.
  • Over 5 years, Other Operating Expenses stood at $551567.0 in 2018, then jumped by 60.04% to $882705.0 in 2019, then tumbled by 196.55% to -$852261.0 in 2020, then jumped by 278.67% to $1.5 million in 2021, then changed by 0.0% to $1.5 million in 2022.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered $1.5 million, $1.5 million, and -$852261.0 for Q3 2022, Q1 2021, and Q4 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Lexaria Bioscience 10.15 Mn 6.54 Mn -

Historic Data

Download Data
DateValue
Aug 31, 2022 1.52 Mn
Feb 28, 2021 1.52 Mn
Nov 30, 2020 -852,261.00
Aug 31, 2020 18,198.00
May 31, 2020 -18,198.00
Nov 30, 2019 882,705.00
Aug 31, 2019 1.11 Mn
May 31, 2019 931,860.00
Feb 28, 2019 1.09 Mn
Nov 30, 2018 551,567.00
Feb 28, 2018 3,998.00
Nov 30, 2017 440,701.00
Aug 31, 2017 727,596.00
May 31, 2017 364,156.00